INDOCO REMEDIES
Back to Balance Sheet
|
INDOCO REMEDIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹609 Cr | ₹604 Cr | ₹422 Cr | ₹205 Cr | ₹157 Cr |
What is the latest Total Non-Current Liabilities ratio of INDOCO REMEDIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹609 Cr |
| Mar2025 | ₹604 Cr |
| Mar2024 | ₹422 Cr |
| Mar2023 | ₹205 Cr |
| Mar2022 | ₹157 Cr |
How is Total Non-Current Liabilities of INDOCO REMEDIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹609 Cr | 0.84 | |
| Mar2025 | ₹604 Cr | 43.05 | |
| Mar2024 | ₹422 Cr | 105.37 | |
| Mar2023 | ₹205 Cr | 31.19 | |
| Mar2022 | ₹157 Cr | - | |
Compare Total Non-Current Liabilities of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹2,238.3 Cr | 8.1% | 10.9% | -12.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,180.0 Cr | 2% | -1.7% | 15.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹243,302.0 Cr | 6.5% | 14.8% | 48.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,623.0 Cr | 1.2% | -2.5% | 37.2% | Stock Analytics | |
| CIPLA | ₹114,554.0 Cr | -0.3% | -3.9% | -11.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,741.0 Cr | -2.2% | 1.5% | -8.3% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | 8.1% |
10.9% |
-12.2% |
| SENSEX | -0.9% |
-1.5% |
-5.8% |
You may also like the below Video Courses